SubjectWell, provider of the most accurate, diverse, predictable, and patient-centric patient recruitment platform, is pleased to announce its acquisition of Trials24, a renowned provider of global digital patient recruitment solutions. The integration of Trials24 into SubjectWell’s operations brings together two industry leaders who share a deep commitment to improving global healthcare. Trials24, with its cutting-edge technology, digital marketing expertise, and engagement center with local native language representatives in more than 13 European countries, joins forces with SubjectWell’s Patient Network of over 13 million patients interested in pursuing new treatments, including 6 million people of color.
Read the full article: SubjectWell Announces Strategic Acquisition of Trials24 to Expand Global Patient Recruitment Capabilities //
Source: https://www.businesswire.com/news/home/20240917339940/en/SubjectWell-announces-strategic-acquisition-of-Trials24-to-expand-global-patient-recruitment-capabilities